US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 5.730
- -0.060-1.04%
Close Oct 31 16:00 ET
- 5.730
- 0.0000.00%
Post 16:09 ET
484.90MMarket Cap-2212P/E (TTM)
5.830High5.620Low1.05MVolume5.770Open5.790Pre Close5.97MTurnover1.68%Turnover RatioLossP/E (Static)84.62MShares20.12052wk High0.89P/B357.56MFloat Cap4.30552wk Low--Dividend TTM62.40MShs Float78.000Historical High--Div YieldTTM3.63%Amplitude4.305Historical Low5.704Avg Price1Lot Size
About Verve Therapeutics Company
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Company Profile
SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Sekar Kathiresan, M.D.
- Chief Executive Officer and Director
- 9.32M
- Joan Nickerson
- Chief Administrative Officer
- --
- Andrew D. Ashe, J.D.
- President and Chief Operating Officer
- --
- Troy Lister, PhD
- Chief Scientific Officer
- --
- Dr. Ourania Tatsis, PhD
- Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
- --
- Allison Dorval
- Chief Financial Officer and Principal Accounting Officer
- 3.48M
- Frederick Fiedorek, M.D.
- Chief Medical Officer
- --
- Dr. Burt A. Adelman, M.D.
- Chairman of the Board
- 451.88K
- Alexander G. Cumbo
- Independent Director
- 405.88K
- Michael F. Maclean
- Independent Director
- 521.07K
- Lonnel Coats
- Independent Director
- 407.38K
- Jodie P. Morrison
- Independent Director
- --
- Sheila Mikhail, J.D.
- Independent Director
- 412.38K
- Dr. Krishna Yeshwant, M.D.
- Independent Director
- 410.88K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data